Agenda.
Thursday 22nd April 2021
Virtual Meeting streaming live from Dublin in April 2021 - check back for agenda updates.
Chair:
Dr Ann Treacy, Mater Private, Dublin
12:55 - 13:05 Welcome Address
Mr Kiaran O’Malley, Mater Misericordiae University Hospital, Dublin
13:05 - 13:20 A Family & Patient Experience of Urological Cancer Care – Gay Byrne’s Story
Ms Suzy Byrne
13:20 - 13:40 Translational Prostate Cancer Epigenomics via Liquid Biopsies
Dr Antoinette Perry, University College Dublin
13:40 - 14:00 Combining Imaging with Biomarkers to Improve the Diagnosis of Prostate Cancer
Dr Hayley Whitaker, University College London
14:00 - 14:20 Reporting Prostate Biopsies in the Era of Active Surveillance, Focal Therapy & MRI Guided Biopsies
Dr Mahul Amin, University of Tennessee Health Sciences Center
14:20 - 14:40 MRI – Have We Found What We’re Looking For?
Prof Caroline Moore, University College London
14:40-15:20 Coffee Break
Chair:
Mr Kiaran O’Malley, Mater Misericordiae University Hospital, Dublin
15:20 - 15:40 PSMA PET/CT for Staging Prostate Cancer - Implications of the ProPSMA Trial
Prof Declan Murphy, Peter MacCallum Cancer Centre, Melbourne
15:40 - 16:00 Salvage Lymphadenectomy in the PSMA Era
Prof Karim Touijer, Memorial Sloan Kettering Cancer Centre, New York
16:00 - 16:20 Implementing a Lu177 PSMA Radionuclide Therapy Program in Ireland
Dr Martin O’Connell, Mater Misericordiae Hospital, Dublin
16:20 - 16:40 Theranostic Opportunities with Lutetium-PSMA
Prof Declan Murphy, Peter MacCallum Cancer Centre, Melbourne
Friday 23rd April 2021
Chair:
Dr Paul Kelly, Bon Secours Hospital UPMC, Cork
08:30 - 08:35 Welcome Back
Mr Kiaran O’Malley, Mater Misericordiae University Hospital, Dublin
08:35 - 08:55 High Intensity Focused Ultrasound for Prostate Cancer- A Look Back at the Last 18 Years
Prof Caroline Moore, University College London
08:55 - 09:15 The Good, The Bad and The Ugly of Salvage Prostatectomy
Mr Paul Cathcart, Guy’s and St Thomas’ Hospital, London
09:15 - 09:35 SBRT in Oligometastatic Prostate Cancer
Dr Pierre Blanchard, Gustave Roussy Cancer Center, Paris
09:35 - 09:55 The Evolving Role of Surgery in Oligometastatic Prostate Cancer
Prof Karim Touijer, Memorial Sloan Kettering Cancer Center, New York
09:55 - 10:15 Systemic Therapy in Patients with Low Volume Metastatic Prostate Cancer
Dr Min Yuen Teo, Memorial Sloan Kettering Cancer Center, New York
10:15 - 10:45 Coffee Break
Chair:
Mr Nick Hegarty, Mater Private Hospital, Dublin
10:45 - 11:10 Renal Cell Carcinoma in 2021: Current Standards & Future Prospects
Dr Yasser Ged, Johns Hopkins Hospital, Baltimore
11:10 - 11:35 Targeted Therapy in Advanced Bladder Cancer
Dr Emmet Jordan, University Hospital Waterford
11:35 - 12:00 Surgical Issues in Testicular Cancer
Prof David Nicol, The Royal Marsden NHS Foundation Trust, London
12:00 - 12:25 Triple Therapy in High Risk Localised Prostate Cancer
Dr Michael Maher, Mater Private Hospital, Dublin
12:25 - 12:50 Single Port Access: A New Generation of Robotic Surgery
Prof Jihad Kaouk, Cleveland Clinic, Ohio
12:50-14:00 Lunch
Chair:
Prof William Watson, University College Dublin
14:00 - 14:20 Statins & Prostate Cancer; Mechanistic Insights from Pathoepidemiology Studies
Dr Emma Allott, Patrick G Johnston Centre for Cancer Research, Queen’s University Belfast
14:20 - 14:40 Targeting Lipogenesis in Castration Resistant Prostate Cancer
Dr Massimo Loda, Weill Cornell Medical Centre, New York
14:40 - 15:00 Tackling Treatment Resistance in Prostate Cancer
Prof Hing Leung, Beatson Institute, Glasgow
15:00 - 15:20 Genomic Testing in Prostate Cancer Care
Dr Terri McVeigh, The Royal Marsden NHS Foundation Trust, London
15:20-15:50 Coffee Break
15:50 - 16:50
Chair: Prof Ray McDermott, Tallaght University Hospital, Dublin
Dr Ciara Barrett, Mater Misericordiae University Hospital
Ms Catherine Dowling, Galway University Hospital
Dr Min Yuen Teo, Memorial Sloan Kettering Cancer Centre, New York
Dr Grainne Govender, St James’s Hospital, Dublin
Dr Cormac Small, Galway Clinic
16:50 End of Proceedings